Saba Capital Management, L.P. sold $2.3M of ECAT (indirect holdings)
Saba Capital Management, L.P. sold 152,342 indirectly-held shares of BlackRock ESG Capital Allocation Term Trust (ECAT) at an average of $15.00 ($14.83–$15.07, $2.29M total) across 2 trades over 2026-09-10 to 2026-09-11.
How this was made
The 30-second read
Why it matters
The disclosed sale reduces Saba Capital's ownership but remains a small fraction of total shares, limiting market impact.
Market read
Primary insider sale with modest size; limited immediate trading relevance.
What to watch
Potential tax‑loss harvesting or liquidity needs for Saba Capital.
Background
Form 4 filings disclose insider transactions; ECAT is an ESG‑focused term trust listed in the US.
Ticker impact
SEC Form 4 shows Saba Capital sold ~2.3M USD of ECAT shares, reducing its stake to 12.8M shares.
Modest downward pressure over the next few days.
Sale size is modest relative to holdings and market cap; impact limited but could influence short-term sentiment.
Market effects
Minimal effect on broader ESG or fixed‑income sector.
US market only.
Low
Counterpoint
The sale could be a routine portfolio adjustment, not a bearish signal.
Key entities
- InvestorSaba Capital Management, L.P.
Insider reporting a sale of ECAT shares.
- IssuerBlackRock ESG Capital Allocation Term Trust
The trust whose shares were sold.